SelectQuote Inc
SLQT1.375USD
+0.015+1.10%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
241.93MMarket Cap
9.45P/E TTM
More Details of SelectQuote Inc Company
SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises the SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expense, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.
SelectQuote Inc Info
Ticker SymbolSLQT
Company nameSelectQuote Inc
IPO dateMay 21, 2020
CEODanker (Timothy Robert)
Number of employees1181
Security typeOrdinary Share
Fiscal year-endMay 21
Address6800 West 115Th Street
CityOVERLAND PARK
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code66211
Phone19132741994
Websitehttps://ir.selectquote.com/investor-home/default.aspx
Ticker SymbolSLQT
IPO dateMay 21, 2020
CEODanker (Timothy Robert)
Company Executives of SelectQuote Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+16.52%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+16.95%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+586.59%
Mr. Sloan Bohlen
Mr. Sloan Bohlen
Investor Relations
Investor Relations
--
--
Mr. William Thomas Grant, III
Mr. William Thomas Grant, III
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Stephanie D. Fisher
Ms. Stephanie D. Fisher
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Raymond F. Weldon
Mr. Raymond F. Weldon
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
--
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
--
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
371.21K
+16.52%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
363.21K
+16.95%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
--
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+586.59%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Pharmacy revenue
728.75M
47.74%
Commission
696.26M
45.61%
Production bonus and other revenue
101.58M
6.65%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pharmacy revenue
728.75M
47.74%
Commission
696.26M
45.61%
Production bonus and other revenue
101.58M
6.65%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Brookside Equity Partners LLC
10.05%
BlackRock Institutional Trust Company, N.A.
5.12%
The Vanguard Group, Inc.
4.65%
Abrams Bison Investments, L.L.C.
4.50%
Mariner Wealth Advisors
3.62%
Other
72.07%
Shareholders
Shareholders
Proportion
Brookside Equity Partners LLC
10.05%
BlackRock Institutional Trust Company, N.A.
5.12%
The Vanguard Group, Inc.
4.65%
Abrams Bison Investments, L.L.C.
4.50%
Mariner Wealth Advisors
3.62%
Other
72.07%
Shareholder Types
Shareholders
Proportion
Investment Advisor
20.42%
Investment Advisor/Hedge Fund
12.12%
Individual Investor
11.45%
Private Equity
10.05%
Hedge Fund
8.07%
Research Firm
2.10%
Corporation
0.62%
Pension Fund
0.29%
Bank and Trust
0.21%
Other
34.67%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
327
94.38M
53.63%
-3.32M
2025Q2
332
110.44M
63.96%
+4.81M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Brookside Equity Partners LLC
17.68M
10.05%
--
--
Sep 20, 2025
BlackRock Institutional Trust Company, N.A.
9.21M
5.23%
-284.53K
-3.00%
Jun 30, 2025
The Vanguard Group, Inc.
8.21M
4.67%
+360.95K
+4.60%
Jun 30, 2025
Abrams Bison Investments, L.L.C.
7.91M
4.5%
--
--
Jun 30, 2025
Mariner Wealth Advisors
6.37M
3.62%
+79.16K
+1.26%
Jun 30, 2025
Grant (William Thomas II)
4.66M
2.65%
+94.89K
+2.08%
Nov 12, 2024
Grant (Robert Clay)
4.32M
2.45%
--
--
Sep 20, 2025
Grant (William Thomas III)
4.20M
2.39%
--
--
Sep 20, 2025
Geode Capital Management, L.L.C.
3.30M
1.88%
+129.93K
+4.10%
Jun 30, 2025
State Street Investment Management (US)
3.10M
1.76%
+13.17K
+0.43%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Micro-Cap ETF
0.06%
Fidelity Enhanced Small Cap ETF
0.04%
WisdomTree US SmallCap Quality Growth Fund
0.04%
Avantis US Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Avantis US Small Cap Value ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
View more
iShares Micro-Cap ETF
Proportion0.06%
Fidelity Enhanced Small Cap ETF
Proportion0.04%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.02%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Avantis US Small Cap Value ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of SelectQuote Inc?
The top five shareholders of SelectQuote Inc are:
Brookside Equity Partners LLC holds 17.68M shares, accounting for 10.05% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 9.21M shares, accounting for 5.23% of the total shares.
The Vanguard Group, Inc. holds 8.21M shares, accounting for 4.67% of the total shares.
Abrams Bison Investments, L.L.C. holds 7.91M shares, accounting for 4.50% of the total shares.
Mariner Wealth Advisors holds 6.37M shares, accounting for 3.62% of the total shares.
Brookside Equity Partners LLC holds 17.68M shares, accounting for 10.05% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 9.21M shares, accounting for 5.23% of the total shares.
The Vanguard Group, Inc. holds 8.21M shares, accounting for 4.67% of the total shares.
Abrams Bison Investments, L.L.C. holds 7.91M shares, accounting for 4.50% of the total shares.
Mariner Wealth Advisors holds 6.37M shares, accounting for 3.62% of the total shares.
What are the top three shareholder types of SelectQuote Inc?
The top three shareholder types of SelectQuote Inc are:
Brookside Equity Partners LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Brookside Equity Partners LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
How many institutions hold shares of SelectQuote Inc (SLQT)?
As of 2025Q3, 327 institutions hold shares of SelectQuote Inc, with a combined market value of approximately 94.38M, accounting for 53.63% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -10.33%.
What is the biggest source of revenue for SelectQuote Inc?
In FY2025, the Pharmacy revenue business generated the highest revenue for SelectQuote Inc, amounting to 728.75M and accounting for 47.74% of total revenue.
